Identification and characterization of a new potent inhibitor targeting CtBP1/BARS in melanoma cells

Angela Filograna(Institute for Experimental Endocrinology and Oncology), Carmen Valente(IBSA Farmaceutici (Italy))
Journal of Experimental & Clinical Cancer Research
May 6, 2024
Cited by 6


Related Papers